Mucopolysaccharidosis type II: skeletal-muscle system involvement

Area of Science:

• Biochemistry
• Genetics
• Cell Biology

Background:

• Mucopolysaccharidosis type II (MPS-II) is a rare lysosomal storage disorder.
• It stems from a deficiency in the enzyme iduronate-2-sulphatase.
• This enzyme is crucial for breaking down dermatan sulfate and heparan sulfate glycosaminoglycans (GAGs).

Purpose of the Study:

• To review the skeletal-muscle system involvement in Mucopolysaccharidosis type II (MPS-II).
• To understand the impact of GAG accumulation on joints and connective tissues in MPS-II patients.

Main Methods:

• Literature review of existing studies on MPS-II.
• Analysis of clinical features related to the skeletal-muscle system in MPS-II.
• Examination of the role of GAGs in connective tissue and joint dysfunction.

Main Results:

• Accumulation of GAGs in joints and connective tissue is a primary cause of skeletal-muscle system dysfunction in MPS-II.
• MPS-II presents a spectrum of clinical severity, from mild to severe forms.
• Skeletal and muscle involvement are significant clinical manifestations of the disorder.

Conclusions:

• The skeletal-muscle system is significantly affected in MPS-II due to GAG accumulation.
• Understanding this involvement is key to managing the diverse clinical manifestations of MPS-II.
• Further research into the mechanisms of GAG accumulation and its impact on musculoskeletal health is warranted.